Perfil
Dr. Gaurav Gupta, MD, is a Managing Partner at JP Morgan Life Sciences Private Capital.
He is on the Board of Directors at NewAmsterdam Pharma BV.
Dr. Gupta was previously employed as an Associate by OrbiMed Advisors Private Equity.
He also served on the board at NewAmsterdam Pharma Co. NV.
He received his undergraduate degree from The Johns Hopkins University, a graduate degree from The Johns Hopkins University and a doctorate degree from Stanford University School of Medicine.
Cargos activos de Gaurav Gupta
| Empresas | Cargo | Inicio |
|---|---|---|
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Gaurav Gupta.
| Empresas | Cargo | Fin |
|---|---|---|
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Analista de Capital Privado | 01/01/2019 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Director/Miembro de la Junta | - |
Formación de Gaurav Gupta.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NewAmsterdam Pharma Co. NV
NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Gaurav Gupta
















